These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9863027)

  • 1. Somatic genetic alterations in human malignant mesothelioma (review).
    Lee WC; Testa JR
    Int J Oncol; 1999 Jan; 14(1):181-8. PubMed ID: 9863027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma.
    Murthy SS; Testa JR
    J Cell Physiol; 1999 Aug; 180(2):150-7. PubMed ID: 10395284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the molecular analysis of human malignant mesothelioma.
    De Rienzo A; Testa JR
    Clin Ter; 2000; 151(6):433-8. PubMed ID: 11211478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in human malignant mesothelioma.
    Balsara BR; Bell DW; Sonoda G; De Rienzo A; du Manoir S; Jhanwar SC; Testa JR
    Cancer Res; 1999 Jan; 59(2):450-4. PubMed ID: 9927061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal deletion in patients with malignant pleural mesothelioma.
    Neragi-Miandoab S; Sugarbaker DJ
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):42-4. PubMed ID: 19346221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma.
    Bell DW; Jhanwar SC; Testa JR
    Cancer Res; 1997 Sep; 57(18):4057-62. PubMed ID: 9307293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity analysis of 13q and 14q in human malignant mesothelioma.
    De Rienzo A; Jhanwar SC; Testa JR
    Genes Chromosomes Cancer; 2000 Jul; 28(3):337-41. PubMed ID: 10862040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent LOH at multiple loci in human malignant mesothelioma with preferential loss of NF2 gene region.
    Pylkkänen L; Sainio M; Ollikainen T; Mattson K; Nordling S; Carpén O; Linnainmaa K; Husgafvel-Pursiainen K
    Oncol Rep; 2002; 9(5):955-9. PubMed ID: 12168054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic and molecular genetic changes in malignant mesothelioma.
    Musti M; Kettunen E; Dragonieri S; Lindholm P; Cavone D; Serio G; Knuutila S
    Cancer Genet Cytogenet; 2006 Oct; 170(1):9-15. PubMed ID: 16965949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma.
    Taguchi T; Jhanwar SC; Siegfried JM; Keller SM; Testa JR
    Cancer Res; 1993 Sep; 53(18):4349-55. PubMed ID: 8364929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
    Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
    Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma.
    Shivapurkar N; Virmani AK; Wistuba II; Milchgrub S; Mackay B; Minna JD; Gazdar AF
    Clin Cancer Res; 1999 Jan; 5(1):17-23. PubMed ID: 9918198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
    Wiest JS; Franklin WA; Drabkin H; Gemmill R; Sidransky D; Anderson MW
    J Cell Biochem Suppl; 1997; 28-29():64-73. PubMed ID: 9589350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
    Pollock PM; Welch J; Hayward NK
    Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma.
    De Rienzo A; Balsara BR; Apostolou S; Jhanwar SC; Testa JR
    Oncogene; 2001 Sep; 20(43):6245-9. PubMed ID: 11593434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas.
    Cheng JQ; Jhanwar SC; Lu YY; Testa JR
    Cancer Res; 1993 Oct; 53(20):4761-3. PubMed ID: 8402655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular genetic progression on nasopharyngeal carcinoma].
    Shao JY; Zeng WF; Zeng YX
    Ai Zheng; 2002 Jan; 21(1):1-10. PubMed ID: 12500388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interphase fish analysis of cell cycle genes in asbestos-treated human mesothelial cells (HMC), SV40-transformed HMC (MeT-5A) and mesothelioma cells (COLO).
    Dopp E; Poser I; Papp T
    Cell Mol Biol (Noisy-le-grand); 2002; 48 Online Pub():OL271-7. PubMed ID: 12643444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.